predictive markers of response to durvalumab w/nab-paclitaxel doxorubicin/cyclophosphamide in tnbc
Published 2 years ago • 125 plays • Length 1:13Download video MP4
Download video MP3
Similar videos
-
27:03
triple negative breast cancer: predictive and prognostic biomarkers for neo/adjuvant therapy
-
8:51
advantages with nab-paclitaxel in tnbc
-
1:34
identifying predictive markers for checkpoint inhibitor response in kidney cancer
-
1:55
predictive biomarkers in breast cancer
-
2:38
olaparib durvalumab as a chemotherapy-free maintenance strategy in platinum treated advanced tnbc
-
1:14
the importance of a biomarker-directed approach in triple-negative breast cancer
-
1:41
whole mutational burden as a predictive marker for response to immunotherapy
-
0:55
prognostic biomarkers of immunotherapy efficacy in breast cancer
-
1:46
exploratory analysis of keynote-522: efs after neoadjuvant pembro chemo vs chemo for early tnbc
-
1:22
dora: durvalumab and olaparib in platinum treated advanced tnbc
-
1:19
relacorilant nab-paclitaxel in recurrent, platinum-resistant ovarian cancer
-
7:08
impassion130: results of atezolizumab plus nab-paclitaxel for frontline tnbc
-
1:30
begonia: durvalumab combinations in advanced tnbc
-
1:24
begonia: durvalumab dato-dxd in advanced tnbc
-
9:53
predictive markers for breast cancer
-
2:09
mario-3: eganelisib in tnbc
-
4:15
five-year dosing, efficacy results for nab-paclitaxel in tnbc
-
1:07
combining 1l chemo-immunotherapy with oleclumab in patients with advanced tnbc
-
3:35
final results of pakt: capivasertib and paclitaxel for tnbc